Cancer Dictionary


betrixaban (01-17-2018)

Generic Name: betrixaban Trade Name: BEVYXXA® For which conditions is this drug approved? BEVYXXA is indicated for the prevention of venous thromboembolism (VTE) in adults who are hospitalized for an acute illness and are have risk factors for VTE. VTE... Continue Reading

BEVYXXA® (01-17-2018)

Generic Name: betrixaban Trade Name: BEVYXXA® For which conditions is this drug approved? BEVYXXA is indicated for the prevention of venous thromboembolism (VTE) in adults who are hospitalized for an acute illness and are have risk factors for VTE. VTE... Continue Reading

BESPONSA™ (01-17-2018)

Generic Name: inotuzumab ozogamicin Trade Name: BESPONSA For which conditions is this drug approved? BESPONSA is indicated for the treatment of adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL). The labeling contains... Continue Reading

inotuzumab ozogamicin (01-17-2018)

Generic Name: inotuzumab ozogamicin Trade Name: BESPONSA For which conditions is this drug approved? BESPONSA is indicated for the treatment of adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL). The labeling contains... Continue Reading

Aliqopa™ (01-17-2018)

Generic Name: copanlisib Trade Name: Aliqopa For which conditions is this drug approved? Aliqopa is indicated for the treatment of adults with relapsed follicular lymphoma who have received at least two prior systemic treatments. Accelerated approval... Continue Reading

copanlisib (01-17-2018)

Generic Name: copanlisib Trade Name: Aliqopa For which conditions is this drug approved? Aliqopa is indicated for the treatment of adults with relapsed follicular lymphoma who have received at least two prior systemic treatments. Accelerated approval... Continue Reading

NERLYNX™ (01-17-2018)

Generic Name: neratinib Trade Name: NERLYNX For which conditions is this drug approved? NERLYNX is indicated for use in adult patients with early-stage. HER2 positive breast cancer following treatment with Herceptin (trastuzumab). What is the mechanism... Continue Reading

neratinib (01-17-2018)

Generic Name: neratinib Trade Name: NERLYNX For which conditions is this drug approved? NERLYNX is indicated for use in adult patients with early-stage. HER2 positive breast cancer following treatment with Herceptin (trastuzumab). What is the mechanism... Continue Reading

Arava® (06-9-2017)

Class: Immunotherapy Generic Name: leflunomide Trade Name: Arava® How is this drug used? Arava is approved for adults with active rheumatoid arthritis (RA). What is the mechanism of action? Arava is an immunomodulatory drug (DMARD) that works by... Continue Reading

leflunomide (06-9-2017)

Class: Immunotherapy Generic Name: leflunomide Trade Name: Arava® How is this drug used? Arava is approved for adults with active rheumatoid arthritis (RA). What is the mechanism of action? Arava is an immunomodulatory drug (DMARD) that works by... Continue Reading

« Previous PageNext Page »